Advanced search
Publication Cover
Cancer Investigation Volume 32, 2014 - Issue 1
Submit an article Journal homepage
188
Views
11
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Blockage of STAT3 Signaling Pathway with a Decoy Oligodeoxynucleotide Inhibits Growth of Human Ovarian Cancer Cells

Ming LiuDepartment of Obstetrics and Gynecology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, People's Republic of ChinaCorrespondence[email protected]
,
Fei WangDepartment of Obstetrics and Gynecology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, People's Republic of China
,
Zeqing WenDepartment of Obstetrics and Gynecology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, People's Republic of China
,
Min ShiDepartment of Obstetrics and Gynecology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, People's Republic of China
&
Hui ZhangDepartment of Obstetrics and Gynecology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, People's Republic of China
Pages 8-12 | Received 09 Sep 2012, Accepted 29 Oct 2013, Published online: 14 Dec 2013

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Xiaolei Zhang, Tao Lu, Yanhui Ma, Rui Li, Yingxin Pang, Hongluan Mao & Peishu Liu. (2020) Novel Nanocomplexes Targeting STAT3 Demonstrate Promising Anti-Ovarian Cancer Effects in vivo. OncoTargets and Therapy 13, pages 5069-5082.
Read now

Articles from other publishers (10)

Sara Molenda, Agata Sikorska, Anna Florczak, Patryk Lorenc & Hanna Dams-Kozlowska. (2023) Oligonucleotide-Based Therapeutics for STAT3 Targeting in Cancer—Drug Carriers Matter. Cancers 15:23, pages 5647.
Crossref
Virginie Mariot, Romain Joubert, Anne-Charlotte Marsollier, Christophe Hourdé, Thomas Voit & Julie Dumonceaux. (2020) A Deoxyribonucleic Acid Decoy Trapping DUX4 for the Treatment of Facioscapulohumeral Muscular Dystrophy. Molecular Therapy - Nucleic Acids 22, pages 1191-1199.
Crossref
Uddalak Bharadwaj, Moses M. Kasembeli, Prema Robinson & David J. Tweardy. (2020) Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution. Pharmacological Reviews 72:2, pages 486-526.
Crossref
Chin-Jui Wu, Vignesh Sundararajan, Bor-Ching Sheu, Ruby Yun-Ju Huang & Lin-Hung Wei. (2019) Activation of STAT3 and STAT5 Signaling in Epithelial Ovarian Cancer Progression: Mechanism and Therapeutic Opportunity. Cancers 12:1, pages 24.
Crossref
Xiaofeng Zhao, Lu Huang, Wanwan Xu, Xiaoyan Chen, Yan Shen, Wenjie Zeng & Xiao Chen. (2017) Physapubescin B inhibits tumorgenesis and circumvents taxol resistance of ovarian cancer cells through STAT3 signaling. Oncotarget 8:41, pages 70130-70141.
Crossref
Uddalak Bharadwaj, Moses M. Kasembeli & David J. Tweardy. 2016. STAT Inhibitors in Cancer. STAT Inhibitors in Cancer 95 161 .
Seyed Mohammad Ali Hosseini Rad, Lida Langroudi, Fatemeh Kouhkan, Laleh Yazdani, Alireza Nouri Koupaee, Sara Asgharpour, Zahra Shojaei, Taravat Bamdad & Ehsan Arefian. (2015) Transcription factor decoy: a pre-transcriptional approach for gene downregulation purpose in cancer. Tumor Biology 36:7, pages 4871-4881.
Crossref
XUHONG ZHU, QIN LI, SHUANG LI, BOTE CHEN & HAIDONG ZOU. (2015) HIF-1α decoy oligodeoxynucleotides inhibit HIF-1α signaling and breast cancer proliferation. International Journal of Oncology 46:1, pages 215-222.
Crossref
Shailendra Giri, Ramandeep Rattan, Mandar Deshpande, Jacie L. Maguire, Zachary Johnson, Rondell P. Graham & Viji Shridhar. (2014) Preclinical Therapeutic Potential of a Nitrosylating Agent in the Treatment of Ovarian Cancer. PLoS ONE 9:6, pages e97897.
Crossref
Ha T. Nguyen, Geng Tian & Mandi M. Murph. (2014) Molecular Epigenetics in the Management of Ovarian Cancer: Are We Investigating a Rational Clinical Promise?. Frontiers in Oncology 4.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.